Detalhe da pesquisa
1.
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes.
Cancer
; 124(6): 1251-1259, 2018 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29231969
2.
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Health Qual Life Outcomes
; 16(1): 127, 2018 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-29914509
3.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med
; 369(2): 111-21, 2013 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-23841729
4.
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
Haematologica
; 101(12): 1544-1552, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27515250
5.
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.
Am J Hematol
; 91(10): 995-1001, 2016 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-27351715
6.
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study.
Lancet Oncol
; 16(15): 1506-1514, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26404501
7.
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
Br J Haematol
; 168(3): 361-70, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25272332
8.
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Ann Hematol
; 94(1): 23-34, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25096636
9.
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.
Haematologica
; 99(4): 788-93, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24241488
10.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Am J Hematol
; 89(2): 119-24, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24122886
11.
International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
Qual Life Res
; 23(3): 825-36, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24026634
12.
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.
Blood
; 117(18): 4716-25, 2011 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-21385856
13.
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood
; 118(25): 6521-8, 2011 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21931113
14.
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
Blood
; 118(17): 4554-60, 2011 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-21750313
15.
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.
Haematologica
; 98(11): 1702-10, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23716539
16.
Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia.
Blood
; 126(22): 2523-4, 2015 Nov 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26453660
17.
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).
Blood
; 115(18): 3776-86, 2010 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-20203266
18.
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.
Blood
; 116(17): 3171-9, 2010 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-20644121
19.
Health related quality of life in Middle Eastern children with beta-thalassemia.
BMC Blood Disord
; 12: 6, 2012 Jun 22.
Artigo
Inglês
| MEDLINE | ID: mdl-22726530
20.
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group.
Ann Hematol
; 91(9): 1371-81, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22543826